- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech High Insider Buying
Hong Kong Pharmaceuticals & Biotech High Insider Buying
Results
14
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
14 companies
CSPC Pharmaceutical Group
Market Cap: HK$92.6b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$8.10
7D
22.4%
1Y
22.2%
Grand Pharmaceutical Group
Market Cap: HK$30.3b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$8.64
7D
-6.0%
1Y
75.3%
SSY Group
Market Cap: HK$8.6b
An investment holding company, research, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.93
7D
-2.7%
1Y
-37.8%
Abbisko Cayman
Market Cap: HK$6.0b
An investment holding company, engages in the research and development of pharmaceutical products in the People’s Republic of China.
2256
HK$9.58
7D
12.8%
1Y
202.2%
CStone Pharmaceuticals
Market Cap: HK$5.4b
A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in China and internationally.
2616
HK$3.96
7D
11.9%
1Y
241.4%
ImmuneOnco Biopharmaceuticals (Shanghai)
Market Cap: HK$5.2b
A biotechnology company, engages in the research and development of immuno-oncology therapies in the People’s Republic of China.
1541
HK$12.88
7D
35.4%
1Y
-12.3%
Jacobson Pharma
Market Cap: HK$2.6b
Through its subsidiaries, develops, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.32
7D
3.9%
1Y
123.7%
JBM (Healthcare)
Market Cap: HK$2.1b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.55
7D
-1.9%
1Y
174.2%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.8b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.22
7D
1.7%
1Y
2.5%
3D Medicines
Market Cap: HK$1.0b
A biopharmaceutical company, researches, develops, and commercializes oncology products and other drug candidates for the treatment of patients with various cancers in the People’s Republic of China.
1244
HK$4.18
7D
8.0%
1Y
-34.9%
Lee's Pharmaceutical Holdings
Market Cap: HK$871.5m
An investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China.
950
HK$1.48
7D
2.1%
1Y
19.4%
Transcenta Holding
Market Cap: HK$657.5m
A clinical stage biopharmaceutical company, engages in the discovery, research, development, manufacture, and commercialization of various drugs for unmet medical needs in the People’s Republic of China and the United States.
6628
HK$1.62
7D
4.5%
1Y
-9.0%
Kintor Pharmaceutical
Market Cap: HK$625.2m
A clinical-stage biotechnology company, engages in researching, developing, and commercializing therapeutic drugs for dermatology and tumors indications with the unmet medical needs in the People’s Republic of China.
9939
HK$1.44
7D
2.9%
1Y
19.0%
Uni-Bio Science Group
Market Cap: HK$507.6m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.085
7D
4.9%
1Y
14.9%